New CELL Study presents groundbreaking pre-clinical work: immune therapy to potentially treat serious influenza A
- MEDI8852 blocked all influenza A with unique binding properties
International team led by Humabs BioMed identifies novel therapeutic antibody candidates isolated from Zika-infected patients
- Broad implications for new strategies to develop Zika virus diagnostics and treatments - Data published in Science*
Humabs BioMed leads paradigm shift in rabies treatment
- Development of broad-spectrum human antibodies for rabies post-exposure prophylaxis - Antibodies broadly neutralize a large panel of rabies and…
Humabs BioMed and the Institute for Research in Biomedicine announce the successful isolation and characterization of a protective, human-derived antibody against Ebola
- International collaboration publishes results in two Science papers - Clinical development to start with support by DARPA